|Bid||5.60 x N/A|
|Ask||5.70 x N/A|
|Day's range||5.50 - 5.50|
|52-week range||3.84 - 10.20|
|Beta (5Y monthly)||0.61|
|PE ratio (TTM)||N/A|
|Earnings date||09 Nov 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
The mean of analysts' price targets for Exscientia PLC Sponsored ADR (EXAI) points to a 68% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Here is how Dynavax Technologies (DVAX) and Exscientia PLC Sponsored ADR (EXAI) have performed compared to their sector so far this year.
OXFORD, England, November 21, 2023--Exscientia plc (Nasdaq: EXAI) today announced that members of Exscientia management will participate in a fireside chat at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28, 2023, at 3:25 p.m. EST (8:25 p.m. GMT).